Gene Editing for CEP290-Associated Retinal Degeneration

Overview of attention for article published in New England Journal of Medicine, May 2024

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (94th percentile)

Mentioned by

news: 104 news outlets
blogs: 12 blogs
policy: 1 policy source
twitter: 208 X users

facebook: 3 Facebook pages
reddit: 7 Redditors
video: 1 YouTube creator
podcasts: 2 podcasts

Readers on

mendeley: 204 Mendeley

So far, Altmetric has seen 240 X posts from 208 X users, with an upper bound of 3,551,528 followers.

@zhaoweiasu @GeneInvesting @Mucoco_42 @Jasonmmast There's newer data showing better efficacy in a 2024 NEJM article. But, to your point about it taking a long time, it did take an extra two years to show... https://t.co/2N6wn6JPPi

mobility and quality of life, with 79% of participants showing improvement in at least one measure of vision function. Read more: https://t.co/IVNiRvo7Eu #GeneTherapy #CRISPR #CEP290 #RetinalDegeneration #InheritedBlindness #Ophthalmology #MedicalResear…

Gene Editing for CEP290-Associated Retinal Degeneration | New England Journal of Medicine https://t.co/wgkqSi2JVq

RT @NEJM: Original Article: Gene Editing for CEP290-Associated Retinal Degeneration (BRILLIANCE) https://t.co/LgSs2RGBZv Editorial: Succ…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 236 additional X posts.